Uniphar Stock

Uniphar EBITDA per Employee

The EBITDA per Employee of Uniphar (UPR.IR) as of Aug 6, 2026 is 49,715.06 EUR. In the previous year, EBITDA per Employee was 46,284.39 EUR — a change of 7.41% (higher).

EBITDA per Employee

49,715.06EUR

YoY

7.41%

Last updated:

EBITDA per Employee of Uniphar is 2026 49,715.06 EUR. EBITDA per Employee of Uniphar was 2025 46,284.39 EUR. It decreases by 7.41% higher compared to the previous year.
Access this data via the Eulerpool API

Uniphar Stock analysis

What does Uniphar do? Uniphar PLC is an Irish company that was founded in 1994 and operates in the healthcare industry. The company is headquartered in Dublin and employs over 2,500 people worldwide. The history of Uniphar began as a pharmacy distribution company that supplied medications to retailers and healthcare facilities. Over the years, however, the company has expanded its business model and now offers a wide range of healthcare products and services. Uniphar's business model encompasses three main areas: Healthcare Services, Commercial & Clinical Supply Chain, and Product Access & Specialty Medicines. In the Healthcare Services area, Uniphar provides consulting services, training, and leadership coaching for healthcare facilities. The Commercial & Clinical Supply Chain division includes the storage, logistics, and distribution of medications, as well as the clinical care of patients. The Product Access & Specialty Medicines division focuses on access to medications with high medical demand and rare diseases. Uniphar also offers a wide range of healthcare products, including generics, branded medications, and medical devices. The company has partnerships with leading pharmaceutical companies such as Pfizer, Eli Lilly, and Merck. In recent years, Uniphar has also made several significant acquisitions to expand and diversify its business. In 2018, the company acquired UK-based pharmaceutical distributor Cahill May Roberts, and in 2019, the acquisition of Durbin, an international supplier of clinical supply products, was completed. Uniphar is committed to improving healthcare in Ireland and worldwide and offers a wide range of products and services to achieve this goal. The company has earned a reputation as a reliable partner for healthcare facilities and pharmaceutical companies and is on a steady growth trajectory. Uniphar is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Uniphar stock

EBITDA per Employee of Uniphar is 49,715.06 EUR in 2026.

EBITDA per Employee of Uniphar changed from 46,284.39 EUR to 49,715.06 EUR, representing a 7.41% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Uniphar since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Uniphar historically and in real time.

Access this data via the Eulerpool API

Workforce — Uniphar

All Key Metrics — Uniphar